Apyx Medical EPS APYX
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2024
- −$0.82
- Latest quarter, Q2 FY24
- −$0.19
- Fiscal year 2023
- −$0.54
Apyx Medical's earnings per share was −$0.82 over the twelve months to Jun 30, 2024.
In its latest quarter, Q2 FY24, it was −$0.19.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2023 | −$0.54 | n/a |
| FY2022 | −$0.67 | n/a |
| FY2021 | −$0.44 | n/a |
| FY2020 | −$0.35 | n/a |
| FY2019 | −$0.59 | n/a |
| FY2018 | −$8.19 | n/a |
| FY2017 | −$0.17 | n/a |
| FY2016 | −$0.15 | −138% |
| FY2015 | $0.40 | n/a |
| FY2014 | −$1.10 | n/a |
| FY2013 | −$0.24 | −700% |
| FY2012 | $0.04 | n/a |
| FY2011 | $0.00 | n/a |
| FY2010 | n/a | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY24 | −$0.19 | n/a | −$0.82 | |
| Q1 FY24 | −$0.22 | n/a | −$0.66 | |
| Q4 FY23 | −$0.28 | n/a | −$0.54 | |
| Q3 FY23 | −$0.13 | n/a | −$0.43 | |
| Q2 FY23 | −$0.03 | n/a | −$0.47 | |
| Q1 FY23 | −$0.10 | n/a | −$0.60 | |
| Q4 FY22 | −$0.17 | n/a | −$0.67 | |
| Q3 FY22 | −$0.17 | n/a | −$0.56 | |
| Q2 FY22 | −$0.16 | n/a | −$0.51 | |
| Q1 FY22 | −$0.17 | n/a | −$0.47 | |
| Q4 FY21 | −$0.06 | n/a | −$0.44 | |
| Q3 FY21 | −$0.12 | n/a | −$0.42 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Apyx Medical's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| APYXApyx Medical | n/m | |
| KEQUKewaunee Scientific | $2.76 | −33% a year |
| APTAlpha Pro Tech | $0.41 | +24% a year |
| PDEXPro DEX | $4.11 | +52% a year |
| UTMDUtah Medical Products | $3.28 | −12% a year |
| NEPHNephros | $0.16 | +33% a year |
| INFUInfuSystem | $0.41 | +78% a year |
| EMBCEmbecta | $1.47 | +3% a year |
| TCMDTactile Systems Technology | $1.08 | +74% a year |
| MDXGMimedx | $0.04 | −81% a year |
| MOVMovado | $1.80 | +137% a year |
| Peer median | $1.27 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Apyx Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.